... Trump's drug pricing blueprint more challenging, and this would be net positive for the sector," RBC Capital Markets biotech analyst Brian Abrahams ...
News
- The 2018 midterms could have a big impact on healthcare issues from Medicaid to the number of ...
- Neurocrine: 3Q Earnings Snapshot
SAN DIEGO (AP) _ Neurocrine Biosciences Inc. (NBIX) on Monday reported third-quarter net income of $50.8 million, after reporting a loss in the same ...
- Ultragenyx: 3Q Earnings Snapshot
The biotechnology company posted revenue of $11.8 million in the period, which also topped Street forecasts. Nine analysts surveyed by Zacks ...
- OKIN BPS to Open San Antonio HQ
OKIN BPS, a Prague-based business process and services provider, has selected San Antonio for the company's U.S. headquarters. The expansion ...
- Key events next week - healthcare
Daré Bioscience (NASDAQ:DARE): PK and tolerability data on ... Aduro Biotech (NASDAQ:ADRO): Preclinical data on ADU-S100 in solid tumors or ... American Academy of Optometry Annual Meeting, San Antonio, TX (4 days).